☰

Sanaz Memarzadeh, Ph.D. - Publications

Affiliations: 
2008 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Moatamed NA, Vahdatshariatpanahi S, Gjertson DW, Sachs CR, Kang Y, Ostrzega N, Huang J, Memarzadeh S. Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers. Plos One. 18: e0291361. PMID 37725629 DOI: 10.1371/journal.pone.0291361  0.301
2022 Singh T, Neal A, Dibernardo G, Raheseparian N, Moatamed NA, Memarzadeh S. Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers. International Journal of Oncology. 60. PMID 35191515 DOI: 10.3892/ijo.2022.5325  0.307
2021 Neal A, Lai T, Singh T, Rahseparian N, Grogan T, Elashoff D, Scott P, Pellegrini M, Memarzadeh S. Combining ReACp53 with Carboplatin to Target High-Grade Serous Ovarian Cancers. Cancers. 13. PMID 34885017 DOI: 10.3390/cancers13235908  0.313
2020 Neal AS, Nunez M, Lai T, Tosevska A, Morselli M, Amneus M, Zakhour M, Moatamed NA, Pellegrini M, Memarzadeh S. Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial Complex Atypical Hyperplasia. Reproductive Sciences (Thousand Oaks, Calif.). PMID 32124398 DOI: 10.1007/S43032-020-00175-W  0.308
2020 Gilbert L, Oaknin A, Matulonis UA, Mantia-Smaldone G, Lim PC, Castro CM, Provencher DM, Memarzadeh S, Wang J, Esteves B, Zweidler-McKay PA, Moore KN, O'Malley DM. Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-agnostic ovarian cancer. Journal of Clinical Oncology. 38: 6004-6004. DOI: 10.1200/Jco.2020.38.15_Suppl.6004  0.304
2019 Lai T, Neal A, Grogan T, Soragni A, Memarzadeh S. A novel peptide that restores p53 function may act synergistically with carboplatin in targeting high-grade serous ovarian cancers Gynecologic Oncology. 154: 254. DOI: 10.1016/J.Ygyno.2019.04.585  0.331
2016 La V, Fujikawa R, Janzen D, Bainvoll L, Memarzadeh S. Abstract LB-131: Birinapant and carboplatin co-therapy can effectively target platinum resistant ovarian cancer initiating cells Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-131  0.429
2015 Soragni A, Janzen DM, Johnson LM, Lindgren AG, Thai-Quynh Nguyen A, Tiourin E, Soriaga AB, Lu J, Jiang L, Faull KF, Pellegrini M, Memarzadeh S, Eisenberg DS. A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas. Cancer Cell. PMID 26748848 DOI: 10.1016/J.Ccell.2015.12.002  0.37
2015 Janzen DM, Tiourin E, Salehi JA, Paik DY, Lu J, Pellegrini M, Memarzadeh S. An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer. Nature Communications. 6: 7956. PMID 26234182 DOI: 10.1038/Ncomms8956  0.37
2015 Tiourin E, Velasco VS, Rosales MA, Sullivan PS, Janzen DM, Memarzadeh S. Tubal Ligation Induces Quiescence in the Epithelia of the Fallopian Tube Fimbria. Reproductive Sciences (Thousand Oaks, Calif.). PMID 25736327 DOI: 10.1177/1933719115574345  0.36
2015 Janzen D, Tiourin E, Salehi J, Lu J, Pellegrini M, Memarzadeh S. Abstract 5331: Targeting CA125 negative high grade serous ovarian cancer stem cells can result in a dramatic reduction in tumor burden Cancer Research. 75: 5331-5331. DOI: 10.1158/1538-7445.Am2015-5331  0.444
2015 Janzen D, Tiourin E, Salehi J, Lu J, Soragni A, Eisenberg D, Pellegrini M, Memarzadeh S. Restoration of apoptosis in serous cancer stem cells sensitizes them to platinum therapy resulting in tumor eradication Gynecologic Oncology. 137: 3. DOI: 10.1016/J.Ygyno.2015.01.004  0.457
2013 Janzen DM, Paik DY, Rosales MA, Yep B, Cheng D, Witte ON, Kayadibi H, Ryan CM, Jung ME, Faull K, Memarzadeh S. Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo. Molecular Cancer Therapeutics. 12: 2917-28. PMID 24222661 DOI: 10.1158/1535-7163.Mct-13-0572  0.582
2013 Janzen DM, Rosales MA, Paik DY, Lee DS, Smith DA, Witte ON, Iruela-Arispe ML, Memarzadeh S. Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy. Cancer Research. 73: 4697-710. PMID 23744837 DOI: 10.1158/0008-5472.Can-13-0930  0.613
2013 Janzen DM, Cheng D, Schafenacker AM, Paik DY, Goldstein AS, Witte ON, Jaroszewicz A, Pellegrini M, Memarzadeh S. Estrogen and progesterone together expand murine endometrial epithelial progenitor cells. Stem Cells (Dayton, Ohio). 31: 808-22. PMID 23341289 DOI: 10.1002/Stem.1337  0.673
2013 Paik DY, Rosales M, Janzen D, Yep B, Cheng D, Witte O, Kayadibi H, Faull K, Memarzadeh S. Abstract 5539: Low levels of estrogen sensitize PTEN-deficient endometrial tumors to poly-ADP ribose polymerase (PARP) inhibitionin vivo. Cancer Research. 73: 5539-5539. DOI: 10.1158/1538-7445.Am2013-5539  0.565
2013 Paik DY, Janzen D, Memarzadeh S. Abstract 5530: Rejuvenation of dissociated cryopreserved human ovarian papillary serous tumor cells in anin vivomodel. Cancer Research. 73: 5530-5530. DOI: 10.1158/1538-7445.Am2013-5530  0.398
2013 Janzen DM, Rosales MA, Paik DY, Smith DA, Cheng D, Witte ON, Iruela-Arispe L, Memarzadeh S. Abstract 4964: Signaling through the progesterone receptor in the tumor microenvironment regulates hormonal sensitivity in endometrial carcinoma. Cancer Research. 73: 4964-4964. DOI: 10.1158/1538-7445.Am2013-4964  0.606
2012 Paik DY, Janzen DM, Schafenacker AM, Velasco VS, Shung MS, Cheng D, Huang J, Witte ON, Memarzadeh S. Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation. Stem Cells (Dayton, Ohio). 30: 2487-97. PMID 22911892 DOI: 10.1002/Stem.1207  0.585
2012 Cai H, Memarzadeh S, Stoyanova T, Beharry Z, Kraft AS, Witte ON. Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer. Cancer Research. 72: 4672-81. PMID 22805308 DOI: 10.1158/0008-5472.Can-12-0228  0.734
2011 Memarzadeh S, Cai H, Janzen DM, Xin L, Lukacs R, Riedinger M, Zong Y, DeGendt K, Verhoeven G, Huang J, Witte ON. Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal. Proceedings of the National Academy of Sciences of the United States of America. 108: 7962-7. PMID 21518863 DOI: 10.1073/Pnas.1105243108  0.753
2011 Cai H, Smith DA, Memarzadeh S, Lowell CA, Cooper JA, Witte ON. Differential transformation capacity of Src family kinases during the initiation of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 108: 6579-84. PMID 21464326 DOI: 10.1073/Pnas.1103904108  0.657
2010 Lukacs RU, Memarzadeh S, Wu H, Witte ON. Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell. 7: 682-93. PMID 21112563 DOI: 10.1016/J.Stem.2010.11.013  0.757
2010 Memarzadeh S, Zong Y, Janzen DM, Goldstein AS, Cheng D, Kurita T, Schafenacker AM, Huang J, Witte ON. Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium. Proceedings of the National Academy of Sciences of the United States of America. 107: 17298-303. PMID 20855612 DOI: 10.1073/Pnas.1012548107  0.671
2010 Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proceedings of the National Academy of Sciences of the United States of America. 107: 2610-5. PMID 20133806 DOI: 10.1073/Pnas.0913873107  0.795
2008 Lukacs RU, Lawson DA, Xin L, Zong Y, Garraway I, Goldstein AS, Memarzadeh S, Witte ON. Epithelial stem cells of the prostate and their role in cancer progression. Cold Spring Harbor Symposia On Quantitative Biology. 73: 491-502. PMID 19022743 DOI: 10.1101/Sqb.2008.73.012  0.706
2007 Memarzadeh S, Xin L, Mulholland DJ, Mansukhani A, Wu H, Teitell MA, Witte ON. Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell. 12: 572-85. PMID 18068633 DOI: 10.1016/J.Ccr.2007.11.002  0.709
2003 Memarzadeh S, Natarajan S, Dandade DP, Ostrzega N, Saber PA, Busuttil A, Lentz SE, Berek JS. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstetrics and Gynecology. 102: 612-9. PMID 12962952 DOI: 10.1016/S0029-7844(03)00569-6  0.303
2002 Ide H, Seligson DB, Memarzadeh S, Xin L, Horvath S, Dubey P, Flick MB, Kacinski BM, Palotie A, Witte ON. Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 99: 14404-9. PMID 12381783 DOI: 10.1073/Pnas.222537099  0.694
2002 Memarzadeh S, Kozak KR, Chang L, Natarajan S, Shintaku P, Reddy ST, Farias-Eisner R, Memarzedeh S. Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer. Proceedings of the National Academy of Sciences of the United States of America. 99: 10647-52. PMID 12130664 DOI: 10.1073/Pnas.152127499  0.359
Show low-probability matches.